Amazing conversations in this video by Ewing Marion Kauffman Foundation about how a turbulent financial market combined with accelerating technologies will affect tomorrow's equity markets by three of the nation's leading market experts.
Following an introduction by Kauffman Foundation President and CEO Carl J. Schramm, the discussion is led by Harold Bradley, chief investment officer of the Kauffman Foundation, and features Duncan Niederauer, CEO of the NYSE Euronext, and Peter Bloom, managing director of General Atlantic Partners, a global growth private equity investor. The 90-minute discussion addresses current challenges in the equities markets and the trading of stocks, bonds and derivative securities in a global marketplace.
Showing posts with label Corporate. Show all posts
Showing posts with label Corporate. Show all posts
Thursday, June 18, 2009
Friday, June 12, 2009
Tuesday, March 17, 2009
In God we trust; all others pay cash
Warren Buffett's annual letter to Berkshire Hathaway share-holders is a highly anticipated, market-moving event. This time he offers his views on the current economy and the business climate. (with Berkshire performance of course)
Worth a read if you have the time.
An excerpt from his letter:
"Amid this bad news, however, never forget that our country has faced far worse travails in the past. In the 20th Century alone, we dealt with two great wars (one of which we initially appeared to be losing); a dozen or so panics and recessions; virulent inflation that led to a 21.5% prime rate in 1980; and the Great Depression of the 1930s, when unemployment ranged between 15% and 25% for many years. America has had no shortage of challenges.
Without fail, however, we’ve overcome them. In the face of those obstacles – and many others – the real standard of living for Americans improved nearly seven-fold during the 1900s, while the Dow Jones Industrials rose from 66 to 11,497. Compare the record of this period with the dozens of centuries during which humans secured only tiny gains, if any, in how they lived. Though the path has not been smooth, our economic system has worked extraordinarily well over time. It has unleashed human potential as no other system has, and it will continue to do so. America’s best days lie ahead."
Read the complete text of Buffett's letter to shareholders on the Berkshire Hathaway Website.
Worth a read if you have the time.
An excerpt from his letter:
"Amid this bad news, however, never forget that our country has faced far worse travails in the past. In the 20th Century alone, we dealt with two great wars (one of which we initially appeared to be losing); a dozen or so panics and recessions; virulent inflation that led to a 21.5% prime rate in 1980; and the Great Depression of the 1930s, when unemployment ranged between 15% and 25% for many years. America has had no shortage of challenges.
Without fail, however, we’ve overcome them. In the face of those obstacles – and many others – the real standard of living for Americans improved nearly seven-fold during the 1900s, while the Dow Jones Industrials rose from 66 to 11,497. Compare the record of this period with the dozens of centuries during which humans secured only tiny gains, if any, in how they lived. Though the path has not been smooth, our economic system has worked extraordinarily well over time. It has unleashed human potential as no other system has, and it will continue to do so. America’s best days lie ahead."
Read the complete text of Buffett's letter to shareholders on the Berkshire Hathaway Website.
Thursday, March 12, 2009
Bigger Pharma
Well, the pharma industry just got bigger.
Merck's $41 billion acquisition of Schering-Plough (Link)
Though Merck & Co. has agreed to pay Schering-Plough Corp. $2.5 billion if it fails to get financing for its proposed $41 billion takeover of the rival drug maker, according to a filing with the Securities Exchange Commission.
Pfizer's takeover of Wyeth for $68 billion. (Link)
Roche's bid of a $47 billion deal with Genentech. (Link)
Another article from CNN Money on Big Pharma's new landscape.
Now, Pfizer, the world's top drug maker, and French firm Sanofi-Aventis are in the race to buy a stake in Indian Wockhardt Ltd's biotechnology business.
I guess the good thing is that economy/recession/meltdown don't seem to affect the biotech industry.
Read about the article: Biotech industry expected to grow despite global meltdown
Merck's $41 billion acquisition of Schering-Plough (Link)
Though Merck & Co. has agreed to pay Schering-Plough Corp. $2.5 billion if it fails to get financing for its proposed $41 billion takeover of the rival drug maker, according to a filing with the Securities Exchange Commission.
Pfizer's takeover of Wyeth for $68 billion. (Link)
Roche's bid of a $47 billion deal with Genentech. (Link)
Another article from CNN Money on Big Pharma's new landscape.
Now, Pfizer, the world's top drug maker, and French firm Sanofi-Aventis are in the race to buy a stake in Indian Wockhardt Ltd's biotechnology business.
I guess the good thing is that economy/recession/meltdown don't seem to affect the biotech industry.
Read about the article: Biotech industry expected to grow despite global meltdown
Monday, January 26, 2009
Biotech Acquisition
US drug manufacturer Pfizer Inc. will acquire rival Wyeth for $68 billion, making it the largest pharmaceutical takeover deal in nearly a decade, the two companies announced early Monday.
Under the terms of the cash-and-stock transaction, each outstanding share of Wyeth common stock will be converted into a shareholder right to receive $33 in cash and 0.985 of a share of Pfizer common stock.
Pfizer will begin to face U.S. generic competition in 2011 for the cholesterol drug Lipitor. Next year, Wyeth loses patent protection on its own top drug, the antidepressant Effexor XR.
Under the terms of the cash-and-stock transaction, each outstanding share of Wyeth common stock will be converted into a shareholder right to receive $33 in cash and 0.985 of a share of Pfizer common stock.
Pfizer will begin to face U.S. generic competition in 2011 for the cholesterol drug Lipitor. Next year, Wyeth loses patent protection on its own top drug, the antidepressant Effexor XR.
Friday, November 14, 2008
Thursday, August 14, 2008
Recruitment
How to recruit the right person for the job?
"Put about 100 bricks in some particular order in a closed room with an open window."
Then send 2 or 3 candidates in the room and close the door.
.
.
.
Leave them alone and come back after 6 hours and then analyze the situation.
.
.
.
If they are counting the bricks. Put them in the Accounts Department.
If they are recounting them.Put them in auditing.
If they have messed up the whole place with the bricks. Put them in engineering.
If they are arranging the bricks in some strange order. Put them in planning.
If they are throwing the bricks at each other. Put them in operations.
If they are sleeping. Put them in security.
If they have broken the bricks into pieces. Put them in information technology.
If they are sitting idle. Put them in human resources.
If they say they have tried different combination's, yet not a brick has been moved. Put them in sales.
If they have already left for the day. Put them in marketing.
If they are staring out of the window. Put them on strategic planning.
.
.
.
And then last but not least. If they are talking to each other and not a single brick has been moved. Congratulate them and put them in top management.
"Put about 100 bricks in some particular order in a closed room with an open window."
Then send 2 or 3 candidates in the room and close the door.
.
.
.
Leave them alone and come back after 6 hours and then analyze the situation.
.
.
.
If they are counting the bricks. Put them in the Accounts Department.
If they are recounting them.Put them in auditing.
If they have messed up the whole place with the bricks. Put them in engineering.
If they are arranging the bricks in some strange order. Put them in planning.
If they are throwing the bricks at each other. Put them in operations.
If they are sleeping. Put them in security.
If they have broken the bricks into pieces. Put them in information technology.
If they are sitting idle. Put them in human resources.
If they say they have tried different combination's, yet not a brick has been moved. Put them in sales.
If they have already left for the day. Put them in marketing.
If they are staring out of the window. Put them on strategic planning.
.
.
.
And then last but not least. If they are talking to each other and not a single brick has been moved. Congratulate them and put them in top management.
Thursday, July 24, 2008
Innovate
Recently came across 'Innocentive' covered in NYTimes.
InnoCentive is an online open innovation marketplace - a "problem solving" web site - that rewards smart people for good ideas. Companies and organizations (seekers) post problems (challenges) that they are unable to solve within their organization to people all over the world (solvers) who win cash prizes for resolving them. It is free to join and if your solution is chosen - you win. Awards range from $5,000 to $1,000,000.
You can use your knowledge and expertise to make a real difference and get paid for solving these problems too. Considering the vast pool of brilliant and creative people with varied expertise available to passionately solve real life problems in the world the success rate is bound to be good. I heard in the Business Week podcast that 40% of the problems are solved which is an exceptional number for the cost and resources.
Sen. John McCain of Arizona, the Republican nominee for president, has proposed that the government offer $300 million to whoever invents a battery compact enough, powerful enough and cheap enough to replace fossil fuels. (something similar to Innocentive)
To see the details of available Challenges and register with InnoCentive click here:
Join Innocentive
If you have the world's brightest minds solving your problem what more do you want?
Concepts like these will definitely help the world become a better place for all of us to live.
InnoCentive is an online open innovation marketplace - a "problem solving" web site - that rewards smart people for good ideas. Companies and organizations (seekers) post problems (challenges) that they are unable to solve within their organization to people all over the world (solvers) who win cash prizes for resolving them. It is free to join and if your solution is chosen - you win. Awards range from $5,000 to $1,000,000.
You can use your knowledge and expertise to make a real difference and get paid for solving these problems too. Considering the vast pool of brilliant and creative people with varied expertise available to passionately solve real life problems in the world the success rate is bound to be good. I heard in the Business Week podcast that 40% of the problems are solved which is an exceptional number for the cost and resources.
Sen. John McCain of Arizona, the Republican nominee for president, has proposed that the government offer $300 million to whoever invents a battery compact enough, powerful enough and cheap enough to replace fossil fuels. (something similar to Innocentive)
To see the details of available Challenges and register with InnoCentive click here:
Join Innocentive
If you have the world's brightest minds solving your problem what more do you want?
Concepts like these will definitely help the world become a better place for all of us to live.
Tuesday, May 13, 2008
Cash is King
What do you do if you have several billion dollars burning a hole in your pocket? Read the wonderful article on Cnn Money.
Click here to read the entire article.
Click here to read the entire article.
Monday, August 6, 2007
Carlos Slim, the richest man in the world
The son of a Mexico City shopkeeper has built a staggering $59 billion fortune. Fortune's Stephanie Mehta tells the inside story of how he made it to the top.
Click here to read the story
Click here to read the story
Subscribe to:
Posts (Atom)